Gilead Sciences, Inc.
CH ˙ SWX ˙ US3755581036
SecurityCH:GILD / Gilead Sciences, Inc.
InstitutionFmr Llc
Latest Disclosed Ownership65,539,476 shares
Ownership 5.30%
Fmr Llc ownership in GILD / Gilead Sciences, Inc.

2026-02-05 - Fmr Llc has filed an SCHEDULE 13G form with the Securities and Exchange Commission (SEC) disclosing ownership of 65,539,476 shares of Gilead Sciences, Inc. (CH:GILD). This represents 5.3 percent ownership of the company. In their previous filing dated 2017-02-14 , Fmr Llc had reported owning 39,678,492 shares, indicating an increase of 65.18 percent.

Institutional Ownership: 13D/G Filings

This table shows a history of the 13D/G filings made by the investor and/or investor group. Note that the share values in this table are not directly comparable to any numbers shown in the 13F table (if any).

File
Date		Effective
Date		Form Prev
Shares		 Latest
Shares		 ΔShares
(Percent)		 Ownership
(Percent)		 ΔOwnership
(Percent)
2026-02-05 2026-02-05 13G 39,678,492 65,539,476 65.18 5.30 76.02
2017-02-14 2017-02-14 13G/A 74,218,669 39,678,492 -46.54 3.01 -41.52
2016-02-12 2016-02-12 13G/A 74,218,669 5.15
2015-02-13 2015-02-13 13G/A 94,625,011 6.27
2014-02-14 2014-02-14 13G/A 114,019,667 7.43
2013-02-14 2013-02-14 13G 55,823,655 7.37
2012-02-14 2012-02-14 13G/A 36,486,327 4.85

Important Note: One of the primary uses of the 13D/G filings is to evaluate the ability of a firm to control a company (ie, the "beneficial ownership"). To that end, firms are required to report not just direct holdings in companies, but indirect holdings that they control. For investment firms, these indirect holdings can include shares in funds they manage, advisory accounts, and in the case of activist campaigns, pledged votes. Therefore, share counts listed in 13D/G filings can differ significantly than share counts listed in 13F filings.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F GILEAD SCIENCES COM 375558103 71,906,290 6,326,800 9.65 10,021,580 24.50 0.1049
2026-02-17 2025-12-31 13F GILEAD SCIENCES COM 375558103 65,579,490 5,263,211 8.73 8,049,227 20.23 0.4104
2025-11-13 2025-09-30 13F GILEAD SCIENCES COM 375558103 60,316,279 360,902 0.60 6,695,107 0.72 0.3481
2025-08-14 2025-06-30 13F GILEAD SCIENCES COM 375558103 59,955,377 1,412,535 2.41 6,647,253 1.33 0.3749
2025-05-12 2025-03-31 13F GILEAD SCIENCES COM 375558103 58,542,842 18,223,410 45.20 6,559,725 76.13 0.4188
2025-02-13 2024-12-31 13F GILEAD SCIENCES COM 375558103 40,319,432 7,157,113 21.58 3,724,306 33.95 0.2223
2024-11-13 2024-09-30 13F GILEAD SCIENCES COM 375558103 33,162,319 14,680,161 79.43 2,780,329 119.26 0.1692
2024-08-13 2024-06-30 13F GILEAD SCIENCES COM 375558103 18,482,158 893,636 5.08 1,268,061 -1.58 0.0812
2024-05-13 2024-03-31 13F GILEAD SCIENCES COM 375558103 17,588,522 490,874 2.87 1,288,359 -6.98 0.0865
2024-02-13 2023-12-31 13F GILEAD SCIENCES COM 375558103 17,097,648 -2,104,011 -10.96 1,385,080 -3.75 0.1064
2023-11-13 2023-09-30 13F GILEAD SCIENCES COM 375558103 19,201,659 -869,555 -4.33 1,438,972 -6.98 0.1244
2023-08-11 2023-06-30 13F GILEAD SCIENCES COM 375558103 20,071,214 -837,868 -4.01 1,546,888 -10.83 0.1297
2023-08-11 2023-03-31 13F/A-1 GILEAD SCIENCES COM 375558103 20,909,082 4,470,179 27.19 1,734,826 22.93 0.1587
2023-05-11 2023-03-31 13F GILEAD SCIENCES COM 375558103 20,909,082 4,470,179 1,734,826 0.1587
2023-02-13 2022-12-31 13F GILEAD SCIENCES COM 375558103 16,438,903 13,498,403 459.05 1,411,280 678.00 0.1402
2022-11-10 2022-09-30 13F GILEAD SCIENCES COM 375558103 2,940,500 1,008 0.03 181,399 -0.16 0.0189
2022-08-12 2022-06-30 13F GILEAD SCIENCES COM 375558103 2,939,492 -3,373,564 -53.44 181,690 -51.59 0.0181
2022-05-13 2022-03-31 13F GILEAD SCIENCES COM 375558103 6,313,056 -1,509,500 -19.30 375,311 -33.92 0.0300
2022-02-14 2021-12-31 13F GILEAD SCIENCES COM 375558103 7,822,556 1,504,295 23.81 567,996 28.70 0.0419
2022-02-14 2021-09-30 13F/A-1 GILEAD SCIENCES COM 375558103 6,318,261 2,809,204 80.06 441,331 82.64 0.0350
2021-11-15 2021-09-30 13F GILEAD SCIENCES COM 375558103 6,318,261 2,809,204 441,331 0.0350
2021-08-13 2021-06-30 13F GILEAD SCIENCES COM 375558103 3,509,057 942,147 36.70 241,634 45.65 0.0189
2021-05-14 2021-03-31 13F GILEAD SCIENCES COM 375558103 2,566,910 -1,190,529 -31.68 165,900 -24.22 0.0142
2021-02-08 2020-12-31 13F GILEAD SCIENCES COM 375558103 3,757,439 -3,952,786 -51.27 218,909 -55.07 0.0195
2020-11-13 2020-09-30 13F GILEAD SCIENCES COM 375558103 7,710,225 -4,892,313 -38.82 487,209 -49.75 0.0492
2020-08-24 2020-06-30 13F/A-1 GILEAD SCIENCES COM 375558103 12,602,538 1,582,739 14.36 969,640 17.70 0.1066
2020-08-13 2020-06-30 13F GILEAD SCIENCES COM 375558103 12,602,538 1,582,739 969,640 23,821.2173
2020-05-14 2020-03-31 13F GILEAD SCIENCES COM 375558103 11,019,799 4,752,475 75.83 823,840 102.29 0.1141
2020-02-07 2019-12-31 13F GILEAD SCIENCES COM 375558103 6,267,324 -1,969,055 -23.91 407,250 -21.99 0.0449
2019-11-13 2019-09-30 13F GILEAD SCIENCES COM 375558103 8,236,379 -4,470,074 -35.18 522,023 -39.19 0.0626
2019-08-13 2019-06-30 13F GILEAD SCIENCES COM 375558103 12,706,453 -179,260 -1.39 858,448 2.48 0.1003
2019-05-13 2019-03-31 13F GILEAD SCIENCES COM 375558103 12,885,713 -1,245,515 -8.81 837,700 -5.23 0.1004
2019-02-13 2018-12-31 13F GILEAD SCIENCES COM 375558103 14,131,228 -4,079,394 -22.40 883,909 -37.13 0.1211
2018-11-09 2018-09-30 13F GILEAD SCIENCES COM 375558103 18,210,622 -1,376,432 -7.03 1,406,043 1.33 0.1582
2018-08-10 2018-06-30 13F GILEAD SCIENCES COM 375558103 19,587,054 -5,107,836 -20.68 1,387,547 -25.47 0.1638
2018-05-14 2018-03-31 13F GILEAD SCIENCES COM 375558103 24,694,890 574,558 2.38 1,861,747 7.74 0.2210
2018-02-12 2017-12-31 13F GILEAD SCIENCES COM 375558103 24,120,332 -3,591,334 -12.96 1,727,981 -23.04 0.2026
2017-11-13 2017-09-30 13F GILEAD SCIENCES COM 375558103 27,711,666 4,674,363 20.29 2,245,201 37.69 0.2714
2017-08-29 2017-06-30 13F/A-1 GILEAD SCIENCES COM 375558103 23,037,303 258,005 1.13 1,630,581 5.39 0.2027
2017-08-11 2017-06-30 13F GILEAD SCIENCES COM 375558103 23,037,303 258,005 1,630,581
2017-05-11 2017-03-31 13F GILEAD SCIENCES COM 375558103 22,779,298 -16,329,195 -41.75 1,547,170 -44.75 0.1966
2017-02-10 2016-12-31 13F GILEAD SCIENCES COM 375558103 39,108,493 -6,485,428 -14.22 2,800,559 -22.37 0.3743
2016-11-14 2016-09-30 13F GILEAD SCIENCES COM 375558103 45,593,921 -24,318,779 -34.78 3,607,390 -38.15 0.4804
2016-08-11 2016-06-30 13F GILEAD SCIENCES COM 375558103 69,912,700 1,734,085 2.54 5,832,118 -6.88 0.7961
2016-05-16 2016-03-31 13F GILEAD SCIENCES COM 375558103 68,178,615 -5,964,172 -8.04 6,262,888 -16.52 0.8665
2016-02-12 2015-12-31 13F GILEAD SCIENCES COM 375558103 74,142,787 -7,939,582 -9.67 7,502,509 -6.91 1.0093
2015-11-10 2015-09-30 13F GILEAD SCIENCES COM 375558103 82,082,369 -4,440,739 -5.13 8,059,669 -20.44 1.1474
2015-08-25 2015-06-30 13F/A-1 GILEAD SCIENCES COM 375558103 86,523,108 -5,513,488 -5.99 10,130,126 12.16 1.2983
2015-08-13 2015-06-30 13F GILEAD SCIENCES COM 375558103 86,523,108 10,130,126
2015-05-14 2015-03-31 13F GILEAD SCIENCES COM 375558103 92,036,596 -2,317,490 -2.46 9,031,551 1.55 1.1504
2015-02-17 2014-12-31 13F GILEAD SCIENCES COM 375558103 94,354,086 1,638,457 1.77 8,893,817 -9.89 1.1573
2014-11-14 2014-09-30 13F GILEAD SCIENCES COM 375558103 92,715,629 -6,121,241 -6.19 9,869,579 20.44 1.3367
2014-08-14 2014-06-30 13F GILEAD SCIENCES COM 375558103 98,836,870 -6,369,358 -6.05 8,194,565 9.92 1.0983
2014-05-15 2014-03-31 13F GILEAD SCIENCES COM 375558103 105,206,228 -5,995,801 -5.39 7,454,913 -10.79 1.0351
2014-02-13 2013-12-31 13F GILEAD SCIENCES COM 375558103 111,202,029 -4,162,433 -3.61 8,356,833 15.27 1.1809
2013-11-14 2013-09-30 13F GILEAD SCIENCES COM 375558103 115,364,462 2,201,197 1.95 7,249,503 25.10 1.1109
2013-09-24 2013-06-30 13F/A-1 GILEAD SCIENCES COM 375558103 113,163,265 113,163,265 5,795,091 0.9486
2013-08-14 2013-06-30 13F GILEAD SCIENCES COM 375558103 113,163,265 5,795,091 0.9486
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.